(Q56992312)
Statements
A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease (English)
0 references
October 2008
0 references
135
0 references
4
0 references
1130-41
0 references